Structural views of the proteins that regulate the heartbeat may help improve existing treatments for cardiac arrhythmias.
A newly identified genetic risk factor for heart block after surgery may help guide the course of postoperative care.
Vanderbilt University Medical Center (VUMC) is the first in the state to enroll patients in a clinical trial testing the effectiveness of the newest implantable device used to reduce stroke risk in patients with non-valvular atrial fibrillation (AF), the most common form of arrhythmia.
Björn Knollmann, M.D., Ph.D., has been named director of the newly formed Vanderbilt Center for Arrhythmia Research and Therapeutics (VanCART).
Variation in the gene for the beta-1 adrenergic receptor increases the risk that a patient will have an abnormal heart rhythm after cardiac surgery.
Reducing heart muscle response to calcium could decrease the risk of fatal arrhythmias after heart attacks.
Accessibility Tools